Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/31/2010EP2167033A1 Once daily oral dosage form comprising tacrolimus
03/31/2010EP2167027A1 The use of oestrogen applied to the penis to reduce hiv infection
03/31/2010EP2166883A2 Foodstuff composition to improve digestibility of foodstuff lipids
03/31/2010EP2166859A1 Quinazoline salt compounds
03/31/2010EP2166858A1 Novel heterocycle compounds and uses thereof
03/31/2010EP2166857A1 Kinase inhibitor compounds
03/31/2010EP2166856A1 Chemical compounds
03/31/2010EP2166855A2 Control of ectoparasites
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010EP2166852A1 Therapeutic pyrazoloquinoline derivatives
03/31/2010EP2166848A1 Spiroindolines as modulators of chemokine receptors
03/31/2010EP2166847A1 Cetp inhibitors derived from benzoxazole arylamides
03/31/2010EP2166846A1 Inhibitors of janus kinases
03/31/2010EP2166844A1 Reduced-mass, long-acting dosage forms
03/31/2010EP2166843A2 Treatment of viral infections by modulation of host cell metabolic pathways
03/31/2010EP2076496B1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
03/31/2010EP1978928B1 Pharmaceutical valatograst compositions and process for manufacturing them
03/31/2010EP1807393B1 Diarylsulfones as 5-ht2a antagonists
03/31/2010EP1786814B1 Bicyclononene derivatives as renin inhibitors
03/31/2010EP1765823B1 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/31/2010EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/31/2010EP1756111B1 Alkyl substituted indoloquinoxalines
03/31/2010EP1756110B1 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT
03/31/2010EP1756054B1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
03/31/2010EP1735311B1 Beta-carbolines useful for treating inflammatory disease
03/31/2010EP1675846B1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h- [1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
03/31/2010EP1635810B1 Inflammatory disease treatment
03/31/2010EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010EP1546107B1 Cox-2 inhibiting pyridine derivatives
03/31/2010EP1536820B1 Cancer therapy using whole glucan particles and antibodies
03/31/2010EP1530724B1 Diagnosis and prevention of cancer cell invasion
03/31/2010EP1341534B1 Compounds having fungicidal activity and processes to make and use same
03/31/2010EP1333823B1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
03/31/2010EP1301194B1 Essential oil combination and therapeutic uses thereof
03/31/2010EP1244460B1 Use of dipyridinium compounds for treating a disease characterized by proliferating cells containing nitric oxide synthase
03/31/2010EP1223923B1 Unsaturated aryl sulfones for protecting normal cells from cytotoxicity of chemotherapeutic agents
03/31/2010EP1194168B1 Methods and products for manipulating uncoupling protein expression
03/31/2010EP1107989B1 Expression and export of angiostatin and endostatin as immunofusins
03/31/2010EP1104290B1 Microemulsions as solid dosage forms for oral administration
03/31/2010CN101688871A Methods for measuring platelet reactivity of patients that have received drug eluting stents
03/31/2010CN101688227A Macrolactams by engineered biosynthesis
03/31/2010CN101688206A dsrna for treating viral infection
03/31/2010CN101688172A Pseudopterosin-producing bacteria and methods of use
03/31/2010CN101687961A Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes
03/31/2010CN101687913A kallikrein 7 modulators
03/31/2010CN101687905A Pure rocuronium bromide
03/31/2010CN101687904A Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
03/31/2010CN101687902A 8-beta-substituted estratrienes as selectively active estrogens
03/31/2010CN101687900A Double-stranded locked nucleic acid compositions
03/31/2010CN101687899A Therapeutic agent for ulcerative colitis comprising mizoribine
03/31/2010CN101687887A Tricyclic nitrogen containing compounds as antibacterial agents
03/31/2010CN101687885A Fused thiazole derivatives as kinase inhibitors
03/31/2010CN101687884A macrolactone derivatives
03/31/2010CN101687883A modulators of cystic fibrosis transmembrane conductance regulator
03/31/2010CN101687882A Non-basic melanin concentrating hormone receptor-1 antagonists
03/31/2010CN101687881A Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
03/31/2010CN101687880A Cysteine protease inhibitors
03/31/2010CN101687879A 5-furopyridinone substituted indazoles
03/31/2010CN101687878A Catecholamine derivatives useful for the treatment of parkinson' s disease
03/31/2010CN101687877A Heterocyclic cyclopamine analogs and methods of use thereof
03/31/2010CN101687875A Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
03/31/2010CN101687874A Pyrrolotriazine kinase inhibitors
03/31/2010CN101687873A Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
03/31/2010CN101687871A Spiro condensed barbituric acid derivatives for use as antibacterial
03/31/2010CN101687870A Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
03/31/2010CN101687869A Heterocyclic compounds useful as MK2 inhibitors
03/31/2010CN101687868A morphinan compounds
03/31/2010CN101687867A imidazoquinolines with immuno-modulating properties
03/31/2010CN101687866A Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
03/31/2010CN101687864A 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors
03/31/2010CN101687863A Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer
03/31/2010CN101687861A Pyrazoles useful in the treatment of inflammation
03/31/2010CN101687860A Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
03/31/2010CN101687858A 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase
03/31/2010CN101687856A Co-crystals and pharmaceutical compositions comprising the same
03/31/2010CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer
03/31/2010CN101687854A Compounds and compositions as C-KIT and PDGFR kinase inhibitors
03/31/2010CN101687853A Pyrimidine derivatives and compositions as C-KIT and PDGFR kinase inhibitors
03/31/2010CN101687852A Thiazoles and pyrazoles useful as kinase inhibitors
03/31/2010CN101687851A organic compounds
03/31/2010CN101687850A Substituted pyrimidines as adenosine receptor antagonists
03/31/2010CN101687849A crystalline forms of solvated ilaprazole
03/31/2010CN101687848A Solid state forms of racemic ilaprazole
03/31/2010CN101687847A N5-(2-ethoxyethyl)-N3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
03/31/2010CN101687844A Imidazole derivatives as CCR2 receptor antagonists
03/31/2010CN101687843A Substituted aromatic heterocyclic compounds as fungicides
03/31/2010CN101687842A modulators of cftr
03/31/2010CN101687841A Benzimidazole derivatives
03/31/2010CN101687840A Benzimidazole amido derivatives as kinase inhibitors
03/31/2010CN101687838A Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/31/2010CN101687835A Hydroxy sulfonate of quinone compounds and their uses
03/31/2010CN101687828A Thiadiazole derivatives as antidiabetic agents
03/31/2010CN101687827A aminodihydrothiazine derivatives substituted with cyclic groups
03/31/2010CN101687826A salts of a selective beta-2 andrenoceptor agonist
03/31/2010CN101687825A desferrithiocin polyether analogues
03/31/2010CN101687824A deuterated morpholinyl compounds
03/31/2010CN101687822A Di(arylamino)aryl compound
03/31/2010CN101687821A protein kinase inhibitors and methods for using thereof
03/31/2010CN101687819A Novel preparation for external use
1 ... 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 ... 7860